Fluorescence Single Particle Tracking for the Characterization of Submicron Protein Aggregates in Biological Fluids and Complex Formulations

Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects

(2010) Jin-Wook Yoo et al.   CURRENT PHARMACEUTICAL DESIGN

Protein aggregation—Pathways and influencing factors

(2010) Wei Wang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Sizing Nanomatter in Biological Fluids by Fluorescence Single Particle Tracking

(2010) Kevin Braeckmans et al.   NANO LETTERS

Critical Evaluation of Nanoparticle Tracking Analysis (NTA) by NanoSight for the Measurement of Nanoparticles and Protein Aggregates

(2010) Vasco Filipe et al.   PHARMACEUTICAL RESEARCH

A therapeutic antibody and its antigen form different complexes in serum than in phosphate-buffered saline: A study by analytical ultracentrifugation

(2009) Barthélemy Demeule et al.   ANALYTICAL BIOCHEMISTRY

A Critical Review of Methods for Size Characterization of Non-Particulate Protein Aggregates

(2009) John Philo   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Structural properties of monoclonal antibody aggregates induced by freeze–thawing and thermal stress

(2009) Andrea Hawe et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Quantitation of protein particles in parenteral solutions using micro-flow imaging

(2008) Chi-Ting Huang et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Protein aggregation: Pathways, induction factors and analysis

(2008) Hanns-Christian Mahler et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality

(2008) John F. Carpenter et al.   JOURNAL OF PHARMACEUTICAL SCIENCES